{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gonorrhée : Questions médicales les plus fréquentes",
"headline": "Gonorrhée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gonorrhée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-04",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gonorrhée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies génitales",
"url": "https://questionsmedicales.fr/mesh/D000091662",
"about": {
"@type": "MedicalCondition",
"name": "Maladies génitales",
"code": {
"@type": "MedicalCode",
"code": "D000091662",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C12.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Gonorrhée",
"alternateName": "Gonorrhea",
"code": {
"@type": "MedicalCode",
"code": "D006069",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ian H Spicknall",
"url": "https://questionsmedicales.fr/author/Ian%20H%20Spicknall",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Olusegun O Soge",
"url": "https://questionsmedicales.fr/author/Olusegun%20O%20Soge",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Eric P F Chow",
"url": "https://questionsmedicales.fr/author/Eric%20P%20F%20Chow",
"affiliation": {
"@type": "Organization",
"name": "From the Melbourne Sexual Health Centre, Alfred Health."
}
},
{
"@type": "Person",
"name": "Christopher K Fairley",
"url": "https://questionsmedicales.fr/author/Christopher%20K%20Fairley",
"affiliation": {
"@type": "Organization",
"name": "From the Melbourne Sexual Health Centre, Alfred Health."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Statewide Mixed-Methods Study of Provider Knowledge and Behavior Administering Expedited Partner Therapy for Chlamydia and Gonorrhea.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35796238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/OLQ.0000000000001668"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automating Case Reporting of Chlamydia and Gonorrhea to Public Health Authorities in Illinois Clinics: Implementation and Evaluation of Findings.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917153",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/38868"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/36091532",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.966813"
}
},
{
"@type": "ScholarlyArticle",
"name": "Partnership types and coital frequency as predictors of gonorrhea and chlamydia among young MSM and young transgender women.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37146303",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09564624231173728"
}
},
{
"@type": "ScholarlyArticle",
"name": "Healthcare provider awareness of the recent FDA approval on first diagnostic tests for extragenital testing for chlamydia and gonorrhea.",
"datePublished": "2022-05-06",
"url": "https://questionsmedicales.fr/article/35533886",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ypmed.2022.107078"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies urogénitales",
"item": "https://questionsmedicales.fr/mesh/D000091642"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies génitales",
"item": "https://questionsmedicales.fr/mesh/D000091662"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gonorrhée",
"item": "https://questionsmedicales.fr/mesh/D006069"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gonorrhée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gonorrhée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gonorrhée",
"description": "Comment diagnostique-t-on la gonorrhée ?\nQuels tests sont utilisés pour la gonorrhée ?\nPeut-on diagnostiquer la gonorrhée sans symptômes ?\nLes tests de dépistage sont-ils recommandés ?\nQuelle est la période d'incubation de la gonorrhée ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gonorrhée",
"description": "Quels sont les symptômes de la gonorrhée chez les hommes ?\nQuels symptômes la gonorrhée provoque-t-elle chez les femmes ?\nLa gonorrhée peut-elle causer des complications ?\nLes symptômes de la gonorrhée sont-ils toujours présents ?\nComment se manifeste une gonorrhée rectale ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gonorrhée",
"description": "Comment prévenir la gonorrhée ?\nLe vaccin contre la gonorrhée existe-t-il ?\nLes relations monogames protègent-elles contre la gonorrhée ?\nLe dépistage est-il important pour la prévention ?\nLes femmes enceintes doivent-elles se faire dépister ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gonorrhée",
"description": "Quel est le traitement standard de la gonorrhée ?\nLes antibiotiques sont-ils efficaces contre la gonorrhée ?\nFaut-il traiter les partenaires sexuels ?\nCombien de temps faut-il pour guérir de la gonorrhée ?\nPeut-on se réinfecter après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gonorrhée",
"description": "Quelles sont les complications possibles de la gonorrhée ?\nLa gonorrhée peut-elle affecter la grossesse ?\nQuels sont les risques d'infection articulaire ?\nLa gonorrhée peut-elle causer des problèmes de santé à long terme ?\nComment la gonorrhée affecte-t-elle les hommes ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gonorrhée",
"description": "Quels sont les principaux facteurs de risque de la gonorrhée ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe sexe masculin est-il un facteur de risque ?\nLes antécédents d'IST augmentent-ils le risque ?\nLes jeunes adultes sont-ils plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D006069?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la gonorrhée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests de laboratoire sur des échantillons d'urine ou des sécrétions."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la gonorrhée ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la culture bactérienne et les tests d'amplification des acides nucléiques."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la gonorrhée sans symptômes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gonorrhée peut être asymptomatique, nécessitant un dépistage régulier."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les personnes à risque, comme les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Quelle est la période d'incubation de la gonorrhée ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La période d'incubation est généralement de 2 à 14 jours après l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la gonorrhée chez les hommes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hommes peuvent ressentir des douleurs lors de la miction et des écoulements purulents."
}
},
{
"@type": "Question",
"name": "Quels symptômes la gonorrhée provoque-t-elle chez les femmes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes peuvent avoir des pertes vaginales anormales et des douleurs pelviennes."
}
},
{
"@type": "Question",
"name": "La gonorrhée peut-elle causer des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications comme la maladie inflammatoire pelvienne."
}
},
{
"@type": "Question",
"name": "Les symptômes de la gonorrhée sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, de nombreuses personnes peuvent être asymptomatiques malgré l'infection."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une gonorrhée rectale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des douleurs rectales, des démangeaisons et des saignements."
}
},
{
"@type": "Question",
"name": "Comment prévenir la gonorrhée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de préservatifs et le dépistage régulier sont des méthodes efficaces de prévention."
}
},
{
"@type": "Question",
"name": "Le vaccin contre la gonorrhée existe-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre la gonorrhée."
}
},
{
"@type": "Question",
"name": "Les relations monogames protègent-elles contre la gonorrhée ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les relations monogames avec un partenaire non infecté réduisent le risque."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il important pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier aide à détecter et traiter les infections précocement."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se faire dépister ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les femmes enceintes afin de prévenir la transmission."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard de la gonorrhée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est une injection de ceftriaxone et un antibiotique oral comme l'azithromycine."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la gonorrhée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antibiotiques sont généralement efficaces, mais des résistances peuvent survenir."
}
},
{
"@type": "Question",
"name": "Faut-il traiter les partenaires sexuels ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est crucial de traiter tous les partenaires sexuels pour éviter la réinfection."
}
},
{
"@type": "Question",
"name": "Combien de temps faut-il pour guérir de la gonorrhée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La guérison est généralement rapide après le traitement, mais un suivi est recommandé."
}
},
{
"@type": "Question",
"name": "Peut-on se réinfecter après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est possible de se réinfecter si l'on a des rapports non protégés avec un partenaire infecté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la gonorrhée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la maladie inflammatoire pelvienne, l'infertilité et des infections articulaires."
}
},
{
"@type": "Question",
"name": "La gonorrhée peut-elle affecter la grossesse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications comme l'accouchement prématuré et la transmission au nouveau-né."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infection articulaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gonorrhée peut provoquer des arthrites, surtout chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "La gonorrhée peut-elle causer des problèmes de santé à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections non traitées peuvent entraîner des problèmes de santé chroniques, comme l'infertilité."
}
},
{
"@type": "Question",
"name": "Comment la gonorrhée affecte-t-elle les hommes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chez les hommes, elle peut causer des infections des testicules et des complications urinaires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de la gonorrhée ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des rapports sexuels non protégés, plusieurs partenaires et un âge jeune."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de contracter la gonorrhée."
}
},
{
"@type": "Question",
"name": "Le sexe masculin est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes, en particulier ceux ayant des rapports sexuels avec d'autres hommes, sont à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'IST augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents d'infections sexuellement transmissibles augmente le risque."
}
},
{
"@type": "Question",
"name": "Les jeunes adultes sont-ils plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes, en particulier ceux de 15 à 24 ans, sont plus vulnérables à la gonorrhée."
}
}
]
}
]
}
Expedited partner therapy (EPT) refers to the practice of having patients diagnosed with chlamydia or gonorrhea deliver medication directly to their partner(s) to treat them presumptively for infectio...
From November to December 2020, we carried out 15 interviews with health providers who currently provide EPT and coded interviews by recurring themes. We then conducted a statewide online survey on se...
Interview themes included the importance of direct provision of partner medication, administrative/pharmacy barriers to treatment, inclusive EPT eligibility, and patient counseling. Of the 623 health ...
Given that over a quarter of respondents did not know expedited partner therapy (EPT)'s legal status, improving provider education may increase EPT provision. More research is needed on system-level b...
Chlamydia and gonorrhea cases continue to rise in Illinois, increasing by 16.4% and 70.9% in 2019, respectively, compared with 2015. Providers are required to report both chlamydia and gonorrhea, as m...
Prior studies consolidated trigger criteria for eCRs, and compared with manual reporting, found it to be more complete. The goal of this project is to pilot standards-based eCR for chlamydia and gonor...
For this study, we selected 8 clinics located on the north, west, and south sides of Chicago to implement the eCRs; these cases were reported to IDPH. The study period was 52 days. The centralized EHR...
During the study period, 183 eCRs representing 135 unique patients were received by IDPH. eCR reported 95% (n=113 cases) of all the chlamydia cases and 97% (n=70 cases) of all the gonorrhea cases repo...
eCR successfully identified and created automated reports for chlamydia and gonorrhea cases in the implementing clinics in Illinois. eCR demonstrated a more complete case report and represents a promi...
Accurate incidence prediction of sexually transmitted diseases (STDs) is critical for early prevention and better government strategic planning. In this paper, four different forecasting models were p...
The annual percentage changes in the incidence of AIDS, gonorrhea, and syphilis were estimated by using joinpoint regression. The performance of four methods, namely, the autoregressive integrated mov...
The morbidities of AIDS and syphilis are on the rise, and the morbidity of gonorrhea has declined in recent years. The optimal ARIMA models were determined: ARIMA(2,1,2)(0,1,1)...
The time series predictive models show their powerful performance in forecasting STDs incidence and can be applied by relevant authorities in the prevention and control of STDs....
Sexually transmitted infections pose a major public health challenge in the United States and this burden is especially acute in subpopulations like young men who have sex with men (YMSM) and young tr...
This study leveraged 3 years of data from a large longitudinal cohort of YMSM-YTW. A series of generalized linear mixed models examined the association between the number of condomless anal sex acts, ...
Results indicated the number of casual partners was associated with gonorrhea [aOR = 1.17 (95% CI: 1.08, 1.26)], chlamydia [aOR = 1.12 (95% CI: 1.05, 1.20)], and any STI [aOR = 1.14 (95% CI: 1.08, 1.2...
These findings suggest the number of casual partners is a consistent predictor of STI infection among YMSM-YTW. This may reflect the quick saturation of risk within partnerships making the number of p...
To assess healthcare provider awareness of the Food and Drug Administration (FDA) 2019 approval of nucleic acid amplification tests (NAAT) using extragenital specimens for chlamydia and gonorrhea, sev...
The Centers for Disease Control and Prevention (CDC) recommends testing patients with chlamydia (CT)/gonorrhea (GC) for other sexually transmitted infections (STIs) and repeating CT/GC testing 3 to 12...
Molecular laboratory testing for CT/GC during January 1, 2013-December 31, 2020 was retrieved from Veterans Health Administration data sources. Patients were evaluated for syphilis, HIV, and repeat CT...
A total of 41,630 of 1,005,761 CT (4.1%) and 17,649 of 1,013,198 GC (1.7%) results were positive. Median ages of positive CT/GC patients were 29 and 36 years, respectively. Repeat testing rates for CT...
Nearly two-thirds of patients did not receive recommended repeat testing, and nearly one-third were not tested for HIV/syphilis. Veterans Health Administration providers may benefit from additional ed...
There is increased heterosexual transmission of syphilis in Australia, an infection with severe outcomes. Australian policy emphasizes increasing sexually transmissible infection knowledge/awareness. ...
Our online sexual health survey was open May 2 to June 21, 2022, to 16- to 29-year-olds in Australia. We asked participants if they were aware of syphilis, their personal risk perception, and perceive...
Among 2018 participants (69.1% women, 48.9% heterosexual), 91.3% had heard of syphilis (vs. 97.2% for chlamydia and 93.3% for gonorrhea). Older (25-29 years; adjusted odds ratio [aOR], 2.4; 95% confid...
Most young Australians are aware of syphilis, but few have comprehensive knowledge about the infection relative to chlamydia/gonorrhea. Considering increasing heterosexual transmission, syphilis healt...
This systematic review was conducted to estimate the respective prevalence of gonorrhea among two high-risk populations in China and determine the epidemiological features of gonorrhea in them....
Systematic review....
PubMed, Web of Science, China National Knowledge Infrastructure, and Wanfang databases were searched to identify studies published between January 1, 1990, and October 31, 2022, with gonorrhea prevale...
We identified 88 prevalence data points from 49 studies in China, with 30,853 participants of FSWs and 5523 participants of MSM. Pooled prevalence of gonorrhea among FSWs and MSM were 6.9% (95% confid...
The prevalence of gonorrhea is high in two high-risk groups in China, with extragenital infections requiring particular attention. The findings of this study will provide evidence to formulate nationa...
Reporting systems are commonly used for chlamydia and gonorrhea surveillance and community burden assessments. Estimates are conservative given high proportions of asymptomatic cases and underreportin...
Confirmed chlamydia and gonorrhea cases reported among active component soldiers were merged with laboratory and medical encounter records indicative of infection to identify incident cases during 201...
Approximately 83% and 76% of respective chlamydia and gonorrhea cases were identified through reporting, compared with 87% and 67% through laboratory records, and 58% for both through medical encounte...
Integration of laboratory and medical encounter data substantially improved burden estimation over reporting alone. Rates generated remain conservative because they only reflect documented cases. Incr...
Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence ...
Electronic health record data from patients diagnosed with CT/NG during 2018-2019 were analyzed. Treatment completion was defined as documentation of Centers for Disease Control and Prevention-recomme...
Most of the 2426 male (86%) and 754 (72%) female patients diagnosed with CT/NG completed treatment in ≤30 days; 74% of male and 36% of female patients were treated same-day. Among 890 male patients no...
Substantial proportions of male and female sexual health clinic patients did not complete treatment. Our findings underscore the need for implementation of highly sensitive and specific point-of-care ...